Variant report
Variant | esv3440791 |
---|---|
Chromosome Location | chr6:32377424-32378884 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000204290 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562965086 | chr6:32377425-32377426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9268506 | chr6:32377470-32377471 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs545365310 | chr6:32377473-32377474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139592473 | chr6:32377512-32377513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9268507 | chr6:32377539-32377540 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs9268508 | chr6:32377588-32377589 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs567524788 | chr6:32377592-32377593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189521820 | chr6:32377624-32377625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181178497 | chr6:32377673-32377674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs28732205 | chr6:32377712-32377713 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
11 | rs549519546 | chr6:32377717-32377718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs375682741 | chr6:32377719-32377720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs377616225 | chr6:32377720-32377721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568909732 | chr6:32377751-32377752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140791734 | chr6:32377815-32377816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7773668 | chr6:32377824-32377825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9268509 | chr6:32377830-32377831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557723559 | chr6:32377846-32377847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62404580 | chr6:32377860-32377861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186579206 | chr6:32377865-32377866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113104921 | chr6:32377878-32377879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370018254 | chr6:32377903-32377904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs111308541 | chr6:32377905-32377906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs28515648 | chr6:32378132-32378133 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs573894918 | chr6:32378151-32378152 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs28570613 | chr6:32378407-32378408 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs9268510 | chr6:32378503-32378504 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs556411657 | chr6:32378557-32378558 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs578047435 | chr6:32378583-32378584 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs9268511 | chr6:32378645-32378646 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs141815567 | chr6:32378646-32378647 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs368213214 | chr6:32378647-32378648 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs9281780 | chr6:32378658-32378659 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs112092299 | chr6:32378683-32378684 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs116023803 | chr6:32378701-32378702 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs558792617 | chr6:32378746-32378747 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs9281782 | chr6:32378762-32378763 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs569912859 | chr6:32378778-32378779 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs9268513 | chr6:32378787-32378788 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs5007266 | chr6:32378834-32378835 | Weak transcription Enhancers Active TSS Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs189839110 | chr6:32378839-32378840 | Weak transcription Enhancers Active TSS Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs5007265 | chr6:32378866-32378867 | Weak transcription Enhancers Active TSS Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs5007264 | chr6:32378877-32378878 | Weak transcription Enhancers Active TSS Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22844521 | CNVD |
Gestational infection | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Encephalopathy | 20692195 | CNVD |
Immune disease | 17576883 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:32368400-32385600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:32374400-32378800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr6:32375400-32378800 | Weak transcription | Fetal Intestine Large | intestine |
4 | chr6:32375800-32378800 | Weak transcription | Duodenum Mucosa | Duodenum |
5 | chr6:32378800-32379000 | Active TSS | Duodenum Mucosa | Duodenum |
6 | chr6:32378800-32379000 | Bivalent Enhancer | Fetal Kidney | kidney |
7 | chr6:32378800-32379400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr6:32378800-32381200 | Enhancers | Fetal Intestine Large | intestine |
9 | chr6:32378800-32381200 | Enhancers | Fetal Intestine Small | intestine |